Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting drug response based on gene expression.

Jacques Robert1, Antoine Vekris, Philippe Pourquier

  • 1Institut Bergonié and Université Victor Segalen Bordeaux 2, 229 cours de l'Argonne, 33076 Bordeaux, France. robert@bergionie.org

Critical Reviews in Oncology/Hematology
|August 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glutathione impacts both <i>Batrachochytrium dendrobatidis</i> virulence and amphibian cellular defence in a chytridiomycosis model.

bioRxiv : the preprint server for biology·2026
Same author

Glutathione Impacts Both Batrachochytrium dendrobatidis Virulence and Amphibian Cellular Defense in a Chytridiomycosis Model.

MicrobiologyOpen·2026
Same author

[Do chemotherapies still have a place in the era of precision medicine?]

Bulletin du cancer·2026
Same author

Using fluorescent in vitro amphibian cell infection models to quantify pathogenicity of Batrachochytrium dendrobatidis.

Methods (San Diego, Calif.)·2026
Same author

[Decoding and guidelines].

Bulletin du cancer·2026
Same author

A miRNA screen reveals a transcriptional network controlling the initiation of mammary organoids.

The FEBS journal·2026
Same journal

Neoadjuvant Immunotherapy in Melanoma: From Pathologic Response to Response-Adapted Management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: implications for tumor biology and therapeutic strategies - a comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long Non-Coding RNAs in Triple-Negative Breast Cancer: Emerging Drivers of Tumor Biology, Prognosis, and Drug Resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative splicing in breast cancer drug resistance: Mechanisms, therapeutic targeting, and clinical translation.

Critical reviews in oncology/hematology·2026
Same journal

Gene Fusions in Non-small cell lung carcinoma (NSCLC): Expert Perspectives and Practical Considerations for routine testing.

Critical reviews in oncology/hematology·2026
Same journal

Opportunities and Challenges of Dihydrodiol dehydrogenase Expression in Hepatocellular carcinoma.

Critical reviews in oncology/hematology·2026
See all related articles

Predicting cancer drug response remains difficult. Research identifies drug resistance mechanisms and uses gene expression profiling to correlate gene activity with drug sensitivity, aiming for personalized cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacogenomics

Background:

  • Predicting individual patient response to chemotherapy is a significant challenge in cancer treatment.
  • Historically, cellular assays for predicting in vitro drug response faced limitations in routine clinical adoption.
  • Numerous mechanisms of anticancer drug resistance have been identified in cell lines, including issues with drug transport, metabolism, target alteration, DNA repair, and cell death pathways.

Purpose of the Study:

  • To review the mechanisms of anticancer drug resistance.
  • To explore the role of molecular biology techniques, particularly gene expression profiling, in understanding drug sensitivity.
  • To discuss the potential of identified genes and proteins as predictive markers for personalized chemotherapy selection.

Main Methods:

Related Experiment Videos

  • Identification of drug resistance mechanisms in cultured cancer cell lines.
  • Application of molecular biology techniques, including differential gene expression analysis.
  • Utilizing gene expression profiling to correlate gene activity with drug sensitivity in vitro and in human cancers.

Main Results:

  • Established correlations between gene expression patterns and the drug sensitivity of tumor cells.
  • Identified specific genes and proteins implicated in various drug resistance mechanisms.
  • Demonstrated the feasibility of using gene expression data to predict drug response.

Conclusions:

  • Gene expression profiling offers a powerful approach to understand and predict anticancer drug response.
  • Identifying predictive markers holds promise for developing more rational and individualized cancer chemotherapy strategies.
  • The integration of molecular data into clinical practice could significantly improve patient outcomes.